Macrophages augment the skeletal muscle proinflammatory response through TNFα following LPS-induced acute lung injury.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
04 2021
Historique:
revised: 03 02 2021
received: 06 10 2020
accepted: 04 02 2021
entrez: 16 3 2021
pubmed: 17 3 2021
medline: 16 7 2021
Statut: ppublish

Résumé

Muscle may contribute to the systemic inflammatory environment during critical illness, but leukocyte interaction and cytokine influence on muscle and its response has not been fully explored in this context. Using an in vivo model of intratracheal lipopolysaccharide (IT LPS)-induced acute lung injury, we show that skeletal muscle rapidly responds with expression of proinflammatory genes, which may be explained by migration of LPS into the circulation. Treatment of mature C2C12 myotubes with LPS at a level achieved in the circulation following IT LPS elicited a proinflammatory cytokine expression profile similar to that of in vivo murine muscle following IT LPS. Stimulation with toll-like receptor (TLR) 2 and 3 agonists provoked comparable responses in C2C12 myotubes. Additionally, co-cultures of C2C12 myotubes and bone marrow-derived macrophages (BMDM) identified the capacity of macrophages to increase myotube proinflammatory gene expression, with tumor necrosis factor-α (TNFα) gene and protein expression largely attributable to BMDM. To investigate the contribution of TNFα in the synergy of the co-culture environment, C2C12 myotubes were treated with recombinant TNFα, co-cultures were established using TNF-deficient BMDM, and co-cultures were also depleted of TNFα using antibodies. To determine whether the in vitro observations were relevant in vivo, mice received intramuscular administration of LPS ± TNFα or TNFα-neutralizing antibodies and showed that TNFα is both sufficient and necessary to induce synergistic cytokine release from muscle. Taken together, these data demonstrate how skeletal muscle tissue may contribute proinflammatory cytokines following acute endotoxin injury and the potential of leukocytes to augment this response via TNFα secretion.

Identifiants

pubmed: 33724561
doi: 10.1096/fj.202002275RR
pmc: PMC7970444
mid: NIHMS1674805
doi:

Substances chimiques

Cytokines 0
Lipopolysaccharides 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21462

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL143452
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL076122
Pays : United States

Informations de copyright

© 2021 Federation of American Societies for Experimental Biology.

Références

Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L379-99
pubmed: 18621912
J Leukoc Biol. 2017 Nov;102(5):1219-1227
pubmed: 28877953
J Biol Chem. 2014 Dec 19;289(51):35237-45
pubmed: 25391648
Am J Pathol. 2014 Apr;184(4):1167-1184
pubmed: 24525152
Am J Pathol. 2013 Feb;182(2):505-15
pubmed: 23201131
Am J Physiol Cell Physiol. 2013 Oct 15;305(8):C877-86
pubmed: 23926130
Crit Care Med. 2005 Apr;33(4):711-5
pubmed: 15818093
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Hum Mol Genet. 2009 Feb 1;18(3):482-96
pubmed: 18996917
Br J Surg. 2010 Mar;97(3):434-42
pubmed: 20035532
J Pain. 2016 Oct;17(10):1081-1094
pubmed: 27377621
J Neuroimmunol. 2000 Jul 1;106(1-2):206-13
pubmed: 10814799
Crit Care Med. 2014 Apr;42(4):849-59
pubmed: 24247473
Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H735-44
pubmed: 19151248
Exerc Immunol Rev. 2015;21:8-25
pubmed: 25826432
Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G204-12
pubmed: 16407590
Intensive Care Med. 1999 Feb;25(2):157-61
pubmed: 10193541
Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1213-C1228
pubmed: 31532714
Thorax. 2018 Oct;73(10):926-935
pubmed: 29980655
Am J Respir Cell Mol Biol. 2012 Sep;47(3):288-97
pubmed: 22538866
J Infect Dis. 2004 Aug 1;190(3):527-34
pubmed: 15243928
Am J Respir Crit Care Med. 2014 Aug 15;190(4):410-20
pubmed: 24825371
Stem Cell Reports. 2017 Dec 12;9(6):2018-2033
pubmed: 29198825
Sci Transl Med. 2015 Mar 11;7(278):278ra32
pubmed: 25761888
JAMA. 1997 Jul 16;278(3):234-40
pubmed: 9218672
Surgery. 1990 Apr;107(4):411-6
pubmed: 2108508
N Engl J Med. 2005 Oct 20;353(16):1685-93
pubmed: 16236739
Clin Infect Dis. 1997 Mar;24(3):430-5
pubmed: 9114195
J Trauma. 1998 Jun;44(6):1031-5; discussion 1035-6
pubmed: 9637159
Nat Med. 2015 Jul;21(7):786-94
pubmed: 26053624
Clin Infect Dis. 2020 May 23;70(11):2413-2422
pubmed: 31260509
J Sports Med (Hindawi Publ Corp). 2018 Apr 16;2018:5724575
pubmed: 29850597
Stem Cells Int. 2019 Jul 14;2019:4761427
pubmed: 31396285
Shock. 2021 May 1;55(5):676-685
pubmed: 32826815
Exp Cell Res. 2008 Oct 15;314(17):3232-44
pubmed: 18775697
Eur J Pharmacol. 2006 Jun 6;539(1-2):131-8
pubmed: 16698012
Calcif Tissue Int. 2015 Mar;96(3):183-95
pubmed: 25294644
J Cell Physiol. 2010 May;223(2):389-96
pubmed: 20082310
Am J Respir Crit Care Med. 2017 Apr 1;195(7):860-870
pubmed: 28157386
Front Immunol. 2020 Feb 07;11:77
pubmed: 32117241
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1153-64
pubmed: 12842862
Ann Am Thorac Soc. 2019 Aug;16(8):947-956
pubmed: 31162935
Scand J Gastroenterol. 1993 Jul;28(7):573-80
pubmed: 8362208
Am J Physiol Endocrinol Metab. 2019 Jul 1;317(1):E85-E98
pubmed: 30964703
FEBS J. 2013 Sep;280(17):4131-48
pubmed: 23663276
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232283
Nat Rev Immunol. 2017 Mar;17(3):165-178
pubmed: 28163303
J Exp Med. 2007 May 14;204(5):1057-69
pubmed: 17485518
Int Immunol. 2000 Sep;12(9):1329-35
pubmed: 10967028

Auteurs

Joseph J Bivona (JJ)

Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Cellular, Molecular, and Biomedical Sciences Doctoral Program, University of Vermont, Burlington, VT, USA.

Hanna M Crymble (HM)

Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.

Blas A Guigni (BA)

Cellular, Molecular, and Biomedical Sciences Doctoral Program, University of Vermont, Burlington, VT, USA.
Department of Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, VT, USA.

Renee D Stapleton (RD)

Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.

D Clark Files (DC)

Department of Internal Medicine, Section on Pulmonary, Critical Care, Allergy, and Immunology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Michael J Toth (MJ)

Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Department of Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, VT, USA.

Matthew E Poynter (ME)

Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.

Benjamin T Suratt (BT)

Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH